Study Stopped
Study data no longer needed
Therapy Cool Path Ablate VT
Ablate-VT
Clinical Evaluation of Therapy Cool Path Duo Cardiac Ablation System for the Treatment of Ischemic Ventricular Tachycardia (VT)
Sponsor study identifier
interventional
20
1 country
5
Study Start
June 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2010
Actual (reported)Study Completion
July 2011
Actual (reported)To demonstrate that ablation with the Therapy Cool Path Duo cardiac ablation system can eliminate ischemic VT and that its use does not result in an unacceptable risk of serious adverse events.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2011
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2009
Date type not reportedThis date has not been verified as actual or estimated.
June 8, 2009
Actual (reported)June 22, 2009
Actual (reported)April 2010
Actual (reported)July 2011
Actual (reported)May 27, 2016
Actual (reported)Primary Safety is Defined as the Incidence of Intra-procedural, Acute or Sub-chronic, Serious Cardiac Adverse Events, up to 7 Days Post-procedure.
7 days
All patients who are eligible receive cardiac ablation procedure for Ischemic Ventricular Tachycardia
Cardiac Ablation Procedure for Ischemic VT using a flexible, insulated 7F all braided catheter that contains an internal lumen connected to 12 open conduits at the 4mm tip electrode for infusion of heparinized saline during radiofrequency ablation; records intracardiac electrograms and can be utilized for cardiac simulation during diagnostic electrophysiologic studies/evaluation. 1500T9-VT generator is a microprocessor-controlled device that produces a continuous unmodulated radiofrequency (RF) output of 485 kHz. The Generator will be used in Temperature Control mode only. The catheter delivers the RF power from the generator in a monopolar mode between its distal electrode (tip electrode) and a large indifferent electrode.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
University Hospital - Univ. of Alabama at Birmingham (UAB)
Birmingham, Alabama, 35233, United States
Loyola University Medical Center
Maywood, Illinois, 60153, United States
Krannert Institute of Cardiology
Indianapolis, Indiana, 46202, United States
Kansas University Medical Center
Kansas City, Kansas, 66160, United States
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
G. Neal Kay, M.D.
University of Alabama at Birmingham
20 participants (actual enrollment reported by the registry).
First Submitted
June 8, 2009
First Posted
June 22, 2009
Study Start
June 2009
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
April 2010
Actual (reported)Study Completion
July 2011
Actual (reported)Last Updated
April 17, 2019
Results First Posted
May 27, 2016
Record last verified: 2019-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: